Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noelyn Hung

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Psychopharmacology|June 12, 2020
Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot studyPaul Glue, Natalie J Medlicott, Shona Neehoff, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 12, 2018
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammationMarina Kazantseva, Sunali Mehta, Ramona A Eiholzer, et al.
The American Journal of Pathology|November 2, 2010
Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeresTania Slatter, Jennifer Gifford-Garner, Anna Wiles, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 14, 2024
Correction: Oral docetaxel plus encequidar - a pharmacokinetic model and evaluation against IV docetaxelDavid Wang, Chris Jackson, Noelyn Hung, et al.
Frontiers in Oncology|September 7, 2013
Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma CellsAnshul Awasthi, Adele G Woolley, Fabienne J Lecomte, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2024
Oral docetaxel plus encequidar - A pharmacokinetic model and evaluation against IV docetaxelDavid Wang, Chris Jackson, Noelyn Hung, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2024
Oral docetaxel plus encequidar - a phase 1 clinical trialDavid Wang, Noelyn Hung, Tak Hung, et al.
Pharmaceutics|May 25, 2024
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical StudyDavid Wang, Natalie Hughes-Medlicott, Lilian Klingler, et al.
Journal of Clinical Pharmacology|January 15, 2016
Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone PharmacokineticsPaul Glue, Gavin Cape, Donna Tunnicliff, et al.
Molecular Neurobiology|October 16, 2012
Telomere profiling: toward glioblastoma personalized medicineSylvain Ferrandon, Paul Saultier, Julien Carras, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Psychopharmacology|June 12, 2020
Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot studyPaul Glue, Natalie J Medlicott, Shona Neehoff, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 12, 2018
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammationMarina Kazantseva, Sunali Mehta, Ramona A Eiholzer, et al.
The American Journal of Pathology|November 2, 2010
Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeresTania Slatter, Jennifer Gifford-Garner, Anna Wiles, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 14, 2024
Correction: Oral docetaxel plus encequidar - a pharmacokinetic model and evaluation against IV docetaxelDavid Wang, Chris Jackson, Noelyn Hung, et al.
Frontiers in Oncology|September 7, 2013
Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma CellsAnshul Awasthi, Adele G Woolley, Fabienne J Lecomte, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2024
Oral docetaxel plus encequidar - A pharmacokinetic model and evaluation against IV docetaxelDavid Wang, Chris Jackson, Noelyn Hung, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2024
Oral docetaxel plus encequidar - a phase 1 clinical trialDavid Wang, Noelyn Hung, Tak Hung, et al.
Pharmaceutics|May 25, 2024
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical StudyDavid Wang, Natalie Hughes-Medlicott, Lilian Klingler, et al.
Journal of Clinical Pharmacology|January 15, 2016
Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone PharmacokineticsPaul Glue, Gavin Cape, Donna Tunnicliff, et al.
Molecular Neurobiology|October 16, 2012
Telomere profiling: toward glioblastoma personalized medicineSylvain Ferrandon, Paul Saultier, Julien Carras, et al.
Pageof 3